Pharma Focus Asia
KP - Sustainable Packaging Solutions

Pfizer Continues Investment in Irish Plants

US-based Pfizer is investing US$130 million into Irish plants, as part of its ongoing expansion plans. Pfizer invests US$100m into Grange Castle, west Dublin biologics unit and US$30m into Ringaskiddy plant in County Cork.

The Department of Jobs, Enterprise and Innovation through IDA Ireland, willsupport the investmentsand will support the sites to expand their capacity in producing more advanced, complex therapies to deal with some of the most dangerous and difficult to cure diseases.

The Ringaskiddy site was Pfizer’s first manufacturing facility in Ireland almost 45 years ago with an investment of more than US$7 billion in developing the skills, scale and capability necessary to manufacture some of Pfizer’s medicines in cancer and other future pipeline medicinesfor global export from Ireland.

After expansion, Grange Castle manufacturing plant will be able to double the production of its rheumatoid arthritis drug Enbrel and will also manufacture new biologics. The expanded facility is expected to be operational in 2015.

Latest Issue
Get instant
access to our latest e-book
MFA + MMA 2024CPHI Chine || PMEC China 2024Asia Healthcare Week 2024Gibco Adherent Kidney Media PanelCPHI Korea 2024Equinix accelerated medical research...CHEMICAL INDONESIA 2024Thermofisher - Antibody Therapeutic PolishingINALAB 2024 Thermo Scientific - DynaDrive and DynaSpinDigital Health Asia 2024Rehab Expo 2024ISPE Singapore Affiliate Conference & Exhibition 20242024 PDA Pharmaceutical Manufacturing & Quality Conference2024 PDA Cell and Gene Pharmaceutical Products Conference 2024 PDA Aseptic Manufacturing Excellence Conference2024 PDA Aseptic Processing of Biopharmaceuticals ConferencePharma Quality Excellence Awards 20244th Annual Pharma GMP Quality Management 20243rd World ADC Asia 2024
Searching for an end-to-end patient tech solution?